Head Office: Delhi/NCR | Other Branches: Lucknow

In a recent preliminary study, afamelanotide (16 mg subcutaneous implant) along with Narrowband UVB has given promising results In Vitiligo – Here is the study report

Narrowband UVB Therapy for Vitiligo

Vitiligo is a chronic skin disorder that affects millions of individuals worldwide. The condition is characterized by the loss of pigmentation of the skin and even hair, typically when the melanin-producing melanocytes in the body are destroyed.

Although no definitive cure for vitiligo has been found, we can’t forego that advancements in treatment have made concealing and treating the symptoms quite accessible for patients.

Recent studies and ongoing clinical studies indicate that the future of vitiligo treatment is highly promising in improving the patient’s disease state and overall quality of life.

However, a recent preliminary study has shown promising results in treating Vitiligo using a combination of afamelanotide and Narrowband UVB therapy. This article will look into an in-depth analysis of the study, discuss the findings and also explore the future implications of these advanced treatments in treating vitiligo.

[lwptoc title=”Table of Content” hideItems=”1″]

Overview of the Study

The study’s findings we will discuss and highlight in this article is a review conducted via a literature search involving data from PubMed and the National Institutes of Health’s clinicalTrials.gov databases between January 2010 to July 2015.

74 studies were reviewed to look into medical and surgical treatment modalities for vitiligo.

Amidst them, two factors that stood out were understanding the efficacy and safety of afamelanotide, a synthetic analog of α-MSH, in combination with Narrowband UVB therapy for Vitiligo treatment.

The objective was to understand how combining these two individual treatment methods into one could promote repigmentation and improve the overall quality of life of Vitiligo patients.

| Related: 10 myths and facts around vitiligo you should know first |

Understanding the Basics First

Before we explore the combined impacts of afamelanotide with Narrowband UVB, we first need to understand these two factors individually.

Afamelanotide: An Introduction

Afamelanotide is a synthetic analog of α-MSH, a naturally occurring hormone that regulates pigmentation.

Its primary function is to bind to the melanocortin-1 receptors in the melanocytes, which, in turn, triggers the production of melanin, the pigment responsible for the distinct color of our skin, hair, eye color, etc.

Afamelanotide’s melanogenesis-inducing properties make it a promising candidate for treating impaired or deficient pigmentation conditions, such as Vitiligo. Not just Vitiligo, afamelanotide has been studied to treat various other skin disorders, including erythropoietic protoporphyria (EPP).

Furthermore, Afamelanotide is administered as a subcutaneous implant (the same as was observed in this study). The implant is responsible for the sustained or controlled release of the medication in the body.

Overall, afamelanotide offers a unique approach to Vitiligo treatment by targeting melanocyte function and promoting melanin production. More on that will be discussed later.

Vitiligo treatment with Kayakalp Global

doctor-patient

Free Consultation

salary

Most Affordable Treatment

customer

1,00,000 + Happy Patients

FSSAI
FSSAI
Approved
stay-at-home

Treatment at Home

medical-team

25 + years of doctors experience

Vitiligo treatment with Kayakalp Global

doctor-patient

Free Consultation

salary

Most Affordable Treatment

customer

1,00,000 + Happy Patients

FSSAI

FSSAI Approved

stay-at-home

Treatment at Home

medical-team

25 + years of doctors experience

| Related: 10 Ways To Increase The Melanin Naturally In Your Skin |

Narrowband UVB Therapy: An Introduction

With a basic understanding of afamelanotide out of the way, the next thing we must look into further is using Narrowband UVB (NB UVB) for vitiligo treatment.

Ultraviolet therapy is one of the most praised treatment options for vitiligo. It is often paired with “innate and cellular immunosuppressive” to promote melanin production in the skin and re-pigment the areas with white patches and macules.

Since this article focuses on UVB and its use in treating vitiligo, let us keep UVA out of the equation for now.

UVB therapy is targeted phototherapy that exposes the affected skin to a narrow range of ultraviolet B wavelengths, primarily between 311-312 nanometers. Certain studies indicate that the use of broad-band UVB therapy has more promising effects as opposed to NB UVB.

However, we fail to realize that broad-band UVB uses harmful wavelengths, which might not be ideal for the skin.

The study conducted by Bansal et al found a notable reduction in the “Vitiligo Area Severity Index (VASI)” in patients that underwent the NB UVB therapy. Not just that, this type of phototherapy also assures better color matching and is thus a preferred line of treatment for many vitiligo patients.

| Related: What Are The Main Reason For Spreading Of Vitiligo And How I Can Stop It |

Study Findings

Now that we have a clear and individual understanding of afamelanotide and narrow-band UVB as individual effective treatments for vitiligo, the next focus of the article is to find a correlation between the effects of the combined use of these two treatments.

According to the findings of a recent study, the researcher concluded, “afamelanotide (16 mg subcutaneous implant) along with Narrowband UVB has promising results In Vitiligo.”

Let us break it down further.

First study:

  • The findings are sourced from a small pilot study where afamelanotide (16mg implant) was implanted monthly in four patients one month after the start of NB UVB therapy, which was done thrice a week.
  • The researchers found significant improvements in repigmentation within a month after initiating the combined treatment. The patients also noticed diffusion of the hyperpigmentation of the GV lesions on the skin.

Second study:

  • In a subsequent Phase 1/2 study involving 55 patients, a comparison was made between combination therapy using 7 to 10-day release afamelanotide 16mg bioresorbable implants along with Narrowband UVB (NB-UVB) therapy and NB-UVB therapy alone.
  • According to the results, the combination therapy (afamelanotide with NB-UVB) led to faster repigmentation of the facial vitiligo patches in the patients (within 41 days) and upper extremity lesions (within 61 days) compared to the NB-UVB therapy alone.
  • Furthermore, the combination therapy also demonstrated a better six-month repigmentation rate in patients with non-segmental vitiligo.

These clinical findings highlight the potential benefits of combining afamelanotide implants with NB-UVB therapy for Vitiligo treatment. The faster repigmentation observed in facial and upper extremity lesions suggests that this treatment approach may be particularly effective for these areas commonly affected by Vitiligo.

Side note: It is important to keep in mind that the use of afamelanotide treatment may induce hyperpigmentation of normal skin, which, in turn, can accentuate the contrast between the pigmentation between the unaffected parts and the affected parts on the skin due to vitiligo. People with lighter skin tones, so this particular factor should be taken into consideration.

| Related: Is Vitiligo Related to Hereditary Or is It Genetic |

Limitations and Further Research

While the benefits of the combination therapy using afamelanotide and NB-UVB seem quite promising for reducing the effects of vitiligo in patients, we also have to prioritize the limitations that come with these clinical findings.

Firstly, the sample size was relatively small, which may limit the generalizability of the findings.

Secondly, the study’s duration was relatively short, so there is a dire need for long-term and more comprehensive research to reach tangible conclusions.

Further research with larger sample sizes, longer follow-up periods, and comparative studies with other treatment modalities is warranted to validate the efficacy, safety, and optimal protocol for this combination treatment approach.

The future of vitiligo treatment seems extremely promising, especially with the advancements we have noticed in the research for a new medication for vitiligo, therapies, and surgical procedures.

It is important to understand that light therapy is developed for cold nations that do not receive adequate sunlight. In a country like India, where sunlight is plenty, the application of Sargan plus ointment with 15 minutes of sun exposure produces the same level of re-pigmentation achieved by UVB therapy at a fraction of the cost. 

Sargan plus ointment is a herbal preparation prepared by the doctors at Kayakalp Global and has been used by thousands of patients who have achieved great results. 

It is also important to understand that any new drug will need extensive research and subsidy to be available to the masses in India at affordable prices; till then, we need to rely on combination therapy developed by Kayakalp Global.

| Related: Best Vitiligo Treatment in Delhi |

Conclusion

The recent preliminary study exploring the combination of afamelanotide and Narrowband UVB therapy for Vitiligo has demonstrated very promising results. It is posing as an effective and well-tolerated treatment option for promoting repigmentation for Vitiligo patients.

At Kayakalp Global, our team of doctors is consistently tailoring the treatment with the latest, effective, and approved medical treatments to restore the quality of life of our patients. Given how promising the combination therapy of afamelanotide and NB-UVB looks, our team is constantly keeping up with the ongoing research and looking forward to the ongoing advancements in Vitiligo management.

Related Posts

safed-daag-ka-ilaaj
July 17, 2024

त्वचा पर safed daag परेशान करने वाले हो सकते हैं और अक्सर विटिलिगो या सोरायसिस जैसी अंतर्निहित स्थितियों का संकेत देते हैं। इन स्थितियों के उपचार के लिए एक विशेष दृष्टिकोण की आवश्यकता होती है जो सर्वोत्तम परिणाम प्राप्त करने के लिए आधुनिक चिकित्सा के साथ पारंपरिक उपचारों को जोड़ती है। Kayakalp Global उन प्रमुख अस्पतालों में से एक है, जो आयुर्वेद और एलोपैथी के संयोजन का उपयोग करके विटिलिगो और सोरायसिस के अपने असाधारण उपचार के लिए प्रसिद्ध है। यह लेख बैंगलोर में उपलब्ध safed daag ka ilaj के विभिन्न पहलुओं पर प्रकाश डालता है साथ ही Kayakalp Global द्वारा अपनाई गई विशेषज्ञता और पद्धतियों पर प्रकाश डालता है। सफ़ेद धब्बों को समझें Safed Daag Ka Ilaaj योजना निर्धारित करने के लिए safed daag के कारण को समझना महत्वपूर्ण है। चिकित्सकीय भाषा में ल्यूकोडर्मा के नाम से जाने जाने वाले सफ़ेद धब्बे कई स्थितियों के कारण हो सकते हैं। सबसे आम में शामिल हैं:- विटिलिगो- विटिलिगो एक ऐसी स्थिति है जिसमें त्वचा अपनी वर्णक कोशिकाओं (pigment cells) को खो देती है, जिससे सफ़ेद धब्बे हो जाते हैं। ये धब्बे शरीर पर कहीं भी दिखाई दे सकते हैं और इनका आकार अलग-अलग हो सकता है। सोरायसिस- सोरायसिस एक ऑटोइम्यून बीमारी है जो त्वचा कोशिकाओं के जीवन चक्र को तेज़ कर देती है। यह त्वचा की सतह पर कोशिकाओं को तेज़ी से जमा होने का कारण बनती है, जिससे पपड़ी और लाल धब्बे बनते हैं जो खुजली और कभी-कभी दर्दनाक हो सकते हैं। पिटिरियासिस अल्बा- पिटिरियासिस अल्बा बच्चों और युवा वयस्कों …

safed-daag-ka-ilaaj
July 17, 2024

विटिलिगो, जिसे आमतौर पर " safed daag" के नाम से जाना जाता है, एक ऐसी स्थिति है जिसमें त्वचा की रंगत कम हो जाती है, जिसके परिणामस्वरूप शरीर के विभिन्न हिस्सों पर सफ़ेद धब्बे पड़ जाते हैं। विटिलिगो के साथ जीना चुनौतीपूर्ण हो सकता है, लेकिन चिकित्सा विज्ञान में प्रगति ने इस स्थिति को प्रभावी ढंग से प्रबंधित करना और उसका इलाज करना संभव बना दिया है। लखनऊ में Kayakalp Global आयुर्वेदिक और एलोपैथिक उपचारों के संयोजन का उपयोग करके safed daag के लिए सबसे अच्छा उपचार प्रदान करता है। इस लेख में, हम विटिलिगो के विभिन्न पहलुओं, इसके लक्षणों, कारणों, जटिलताओं और Kayakalp Global में उपलब्ध अभिनव उपचार विकल्पों का पता लगाएंगे। यदि आप या आपका कोई प्रियजन सफेद दाग से जूझ रहा है, तो परामर्श के लिए Kayakalp Global से संपर्क करने में संकोच न करें। डॉ. शैलेन्द्र धवन और उनकी टीम हर कदम पर आपका साथ देने के लिए मौजूद हैं, आपको अपना आत्मविश्वास वापस पाने और अपने जीवन की गुणवत्ता में सुधार करने में मदद करने के लिए उचित देखभाल और प्रभावी safed daag ka ilaj समाधान प्रदान करती हैं। Safed daag (विटिलिगो) को समझें सफ़ेद दाग या विटिलिगो, एक पुरानी त्वचा की स्थिति है जो मेलानोसाइट्स के विनाश या खराबी के कारण होती है, ये कोशिकाएं मेलेनिन के उत्पादन के लिए ज़िम्मेदार होती हैं, जो त्वचा को उसका रंग देने वाला रंगद्रव्य है। नतीजतन, त्वचा पर सफ़ेद धब्बे दिखाई देते हैं। ये धब्बे आकार और स्थान में भिन्न हो सकते हैं, और समय के साथ …

MythVsRealityaboutvitiligo | Kayakalp
July 16, 2024

क्या आप भी स्वादिष्ट समुद्री भोजन का आनंद लेना पसंद करते हैं लेकिन उसके बाद अपना पसंदीदा दूध का गिलास पीने के विचार से डरते हैं? यदि आप भी हममें से कई लोगों की तरह हैं, तो आपने सुना होगा कि मछली खाने के बाद दूध पीना सही नहीं होता है। 

Bacchokechehareparsafeddaag | Kayakalp
July 16, 2024

बच्चों में चेहरे पर सफेद दाग, त्वचा की सबसे आम समस्या है। यह एलर्जी और पोषण संबंधी कमियों सहित विभिन्न स्थितियों के कारण हो सकता है।

thyroid-function-tests-for-vitiligo
July 12, 2024

Vitiligo is a chronic autoimmune disorder characterized by visible white patches all over the skin. Beyond the physical complications, the condition is also known to affect people’s mental well-being, leading to issues with self-esteem and confidence. Owing to the fact that vitiligo is an autoimmune disorder, a lot of its symptoms often coincide with other autoimmune disorders, including thyroid complications. This explains the need for comprehensive thyroid function tests to determine the patient's proper diagnosis of vitiligo. If you are curious to understand the correlation between the importance of thyroid function tests and their influence on vitiligo diagnosis, we have curated a comprehensive guide for you. Understanding Thyroid Function and Its Connection to Vitiligo The thyroid gland, which is present in the neck produces hormones responsible for the regulation of metabolism, growth, and development. The key hormones that the thyroid gland produces are thyroxine (T4) and triiodothyronine (T3). The thyroid-stimulating hormone (TSH), which is secreted by the pituitary gland, is what regulates and governs the proper secretion of the associated thyroid hormones in the body.  Autoimmune thyroid diseases such as Hashimoto's thyroiditis and Graves' disease are common in individuals with vitiligo. Hashimoto's thyroiditis leads to hypothyroidism (underactive thyroid), while Graves' disease causes hyperthyroidism (overactive thyroid). Since both conditions can significantly impact overall health, individuals with vitiligo must undergo thyroid function tests regularly. What are the Varying Thyroid Function Tests (TFTs)? Our specialists at Kayakalp Global prioritize a comprehensive approach to diagnosis. We leave no stones unturned, primarily because we aim …

Leave a Reply

Your email address will not be published. Required fields are marked *

Continue with WhatsApp

x
+91
Consult Now Get a Call Back

Continue with Phone

x
+91